Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors (Q44366594)

2 December 2017

Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors (English)

1 reference

2 December 2017

Tadashi Terasaka

1

1 reference

2 December 2017

Isao Nakanishi

2

1 reference

2 December 2017

Katsuya Nakamura

3

1 reference

2 December 2017

Yoshiteru Eikyu

4

1 reference

2 December 2017

Takayoshi Kinoshita

5

1 reference

2 December 2017

Nobuya Nishio

6

1 reference

2 December 2017

Akihiro Sato

7

1 reference

2 December 2017

Masako Kuno

8

1 reference

2 December 2017

Nobuo Seki

9

1 reference

2 December 2017

Kazuo Sakane

10

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

2 December 2017

1 reference

2 December 2017

13

1 reference

2 December 2017

6

1 reference

2 December 2017

1115-1118

1 reference

Direct association of adenosine deaminase with a T cell activation antigen, CD26

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Biochemistry of Diseases of Immunodevelopment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Adenosine deaminase inhibitors: synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R-nonyl)adenine [(+)-EHNA]

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

Probing the functional role of two conserved active site aspartates in mouse adenosine deaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900026-X

7 January 2021

10.1016/S0960-894X(03)00026-X

Identifiers

DOI

1 reference

2 December 2017

1 reference